Colorectal cancer screening using a stool DNA-based SDC2 methylation test: a multicenter, prospective trial

Gastrointestinal Cancer

Evaluating the effects of a risk-adapted screening program for familial colorectal cancer in individuals between 25 and 50 years of age: study protocol for the prospective population-based intervention study FARKOR

BMC Gastroenterol.

Hoffmann S, Crispin A, Lindoerfer D, Sroczynski G, Siebert U, Mansmann U, Consortium F

doi: 10.1186/s12876-020-01247-6.

ColonoscopyGastrointestinal Cancer

Multiple rounds of one sample versus two sample faecal immunochemical test-based colorectal cancer screening: a population-based study

Lancet Gastroenterol Hepatol.

Schreuders EH, Grobbee EJ, Nieuwenburg SAV, Kapidzic A, van Roon AHC, van Vuuren AJ, Lansdorp-Vogelaar I, Spijker WWJ, Izelaar K, Bruno MJ, Kuipers EJ, Spaander MCW

doi: 10.1016/S2468-1253(19)30176-1.

ColonoscopyGastrointestinal Cancer

Colorectal cancer screening with faecal immunochemical testing, sigmoidoscopy or colonoscopy: a clinical practice guideline

BMJ.

Helsingen LM, Vandvik PO, Jodal HC, Agoritsas T, Lytvyn L, Anderson JC, Auer R, Murphy SB, Almadi MA, Corley DA, Quinlan C, Fuchs JM, McKinnon A, Qaseem A, Heen AF, Siemieniuk RAC, Kalager M, Usher-Smith JA, Lansdorp-Vogelaar I, Bretthauer M, Guyatt G

doi: 10.1136/bmj.l5515.

Gastrointestinal Cancer

Prostate cancer screening using a combination of risk-prediction, MRI, and targeted prostate biopsies (STHLM3-MRI): a prospective, population-based, randomised, open-label, non-inferiority trial

Lancet Oncol

Nordström T, Discacciati A, Bergman M, Clements M, Aly M, Annerstedt M, Glaessgen A, Carlsson S, Jäderling F, Eklund M, Grönberg H, STHLM3 study group.

doi: 10.1016/S1470-2045(21)00348-X

ColonoscopyGastrointestinal Cancer

Cost-effectiveness analysis of colorectal cancer screening using colonoscopy, fecal immunochemical test, and risk score

J Gastroenterol Hepatol.

Sekiguchi M, Igarashi A, Sakamoto T, Saito Y, Esaki M, Matsuda T

doi: 10.1111/jgh.15033.

Gastrointestinal Cancer

Prospective multicenter real-world RAS mutation comparison between OncoBEAM-based liquid biopsy and tissue analysis in metastatic colorectal cancer

doi: 10.1038/s41416-018-0293-5.

ColonoscopyGastrointestinal Cancer

Effect of a Single Aspirin Dose Prior to Fecal Immunochemical Testing on Test Sensitivity for Detecting Advanced Colorectal Neoplasms: A Randomized Clinical Trial

JAMA.

Brenner H, Calderazzo S, Seufferlein T, Ludwig L, Dikopoulos N, Mangold J, Böck W, Stolz T, Eisenbach T, Block T, Kopp-Schneider A, Czock D, Tikk K

doi: 10.1001/jama.2019.4755.

Gastrointestinal Cancer

Telephone versus in-person colorectal cancer risk and screening intervention for first-degree relatives: A randomized controlled trial

Cancer.

Esplen MJ, Harrington S, Leung YW, Aronson M, Rothenmund H, Semotiuk K, Wong J, Gallinger S, Dicks E, McLaughlin J

doi: 10.1002/cncr.32032.

Colonoscopy

Clinical Practice Guideline on Screening for Colorectal Cancer in individuals with a Family History of Nonhereditary Colorectal Cancer or Adenoma: The Canadian Association of Gastroenterology Banff Consensus

Gastroenterology.

Leddin D, Lieberman DA, Tse F, Barkun AN, Abou-Setta AM, Marshall JK, Samadder NJ, Singh H, Telford JJ, Tinmouth J, Wilkinson AN, Leontiadis GI

doi: 10.1053/j.gastro.2018.08.017.

Related content

Evaluating the effects of a risk-adapted screening program for familial colorectal cancer in individuals between 25 and 50 years of age: study protocol for the prospective population-based intervention study FARKOR

Multiple rounds of one sample versus two sample faecal immunochemical test-based colorectal cancer screening: a population-based study

Colorectal cancer screening with faecal immunochemical testing, sigmoidoscopy or colonoscopy: a clinical practice guideline

Prostate cancer screening using a combination of risk-prediction, MRI, and targeted prostate biopsies (STHLM3-MRI): a prospective, population-based, randomised, open-label, non-inferiority trial

Cost-effectiveness analysis of colorectal cancer screening using colonoscopy, fecal immunochemical test, and risk score

Prospective multicenter real-world RAS mutation comparison between OncoBEAM-based liquid biopsy and tissue analysis in metastatic colorectal cancer

Effect of a Single Aspirin Dose Prior to Fecal Immunochemical Testing on Test Sensitivity for Detecting Advanced Colorectal Neoplasms: A Randomized Clinical Trial

Telephone versus in-person colorectal cancer risk and screening intervention for first-degree relatives: A randomized controlled trial

Clinical Practice Guideline on Screening for Colorectal Cancer in individuals with a Family History of Nonhereditary Colorectal Cancer or Adenoma: The Canadian Association of Gastroenterology Banff Consensus